Key Extracellular Proteins and TF-miRNA Co-regulatory Network in Diabetic Foot Ulcer: Bioinformatics and Experimental Insights

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2024 Jul 22

PMID 39037979

Authors

Guanlin Lin

Ximing Liu

Affiliations

Soon will be listed here.

Abstract

Background: Diabetic foot ulcers (DFUs), a serious complication of diabetes, are associated with abnormal extracellular protein (EP) metabolism. The identification of key EPs and their regulatory networks is crucial for the understanding of DFU formation and development of effective treatments. In this study, a large-scale bioinformatics analysis was conducted to identify potential therapeutic targets and experimental validation was performed to ensure the reliability and biological relevance of the findings.

Methods: Due to the comprehensive profiling of DFU samples provided by the GSE80178 dataset, we initially selected it to derive differentially expressed genes (DEGs) associated with DFU. Subsequently, utilizing the UniProt database and annotated EP list from the Human Protein Atlas annotation database, we screened for extracellular protein-related differentially expressed genes (EP-DEGs) due to their crucial role in the pathogenesis and healing of DFU. We examined EP-DEG pathway enrichment and protein-protein interaction networks, analyzed paired full-thickness skin tissue samples from 24 patients with DFUs and healthy controls, and performed polymerase chain reaction (PCR) experiments to validate candidate genes. Ultimately, we constructed a transcription factor (TF)-microRNA (miRNA)-hub gene co-regulatory network to explore upstream and downstream regulatory connections based on validated DEGs.

Results: Four crucial candidate genes (FMOD, LUM, VCAN, and S100A12) were identified and verified via PCR analysis. The TF-miRNA-hub EP-DEG regulatory network contained the pivotal TFs TRIM28 and STAT3 and the miRNAs hsa-mir-20a-5p, hsa-miR-21, and hsa-miR-203.

Conclusion: The findings of this study advance our understanding of the pathology of DFU by defining key roles of specific EPs and elucidating a comprehensive regulatory network. These insights pave the way for novel approaches to improve DFU treatment outcomes.

References

Rousselle P, Montmasson M, Garnier C . Extracellular matrix contribution to skin wound re-epithelialization. Matrix Biol. 2018; 75-76:12-26. DOI: 10.1016/j.matbio.2018.01.002. View

Lachmann A, Xu H, Krishnan J, Berger S, Mazloom A, Maayan A . ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics. 2010; 26(19):2438-44. PMC: 2944209. DOI: 10.1093/bioinformatics/btq466. View

Liu Z, Wu C, Miao H, Wu H . RegNetwork: an integrated database of transcriptional and post-transcriptional regulatory networks in human and mouse. Database (Oxford). 2015; 2015. PMC: 4589691. DOI: 10.1093/database/bav095. View

. Gene Ontology Consortium: going forward. Nucleic Acids Res. 2014; 43(Database issue):D1049-56. PMC: 4383973. DOI: 10.1093/nar/gku1179. View

. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053):1659-1724. PMC: 5388856. DOI: 10.1016/S0140-6736(16)31679-8. View

Gohar F, Anink J, Moncrieffe H, van Suijlekom-Smit L, Prince F, van Rossum M . S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic Arthritis. J Rheumatol. 2018; 45(4):547-554. PMC: 5880729. DOI: 10.3899/jrheum.170438. View

Rojas A, Anazco C, Gonzalez I, Araya P . Extracellular matrix glycation and receptor for advanced glycation end-products activation: a missing piece in the puzzle of the association between diabetes and cancer. Carcinogenesis. 2018; 39(4):515-521. DOI: 10.1093/carcin/bgy012. View

Wang S, Song R, Wang Z, Jing Z, Wang S, Ma J . S100A8/A9 in Inflammation. Front Immunol. 2018; 9:1298. PMC: 6004386. DOI: 10.3389/fimmu.2018.01298. View

Ross K . MiR equal than others: MicroRNA enhancement for cutaneous wound healing. J Cell Physiol. 2021; 236(12):8050-8059. DOI: 10.1002/jcp.30485. View

10.

Jia Z, Liu L, Zhang S, Zhao X, Luo L, Tang Y . Proteomics changes after negative pressure wound therapy in diabetic foot ulcers. Mol Med Rep. 2021; 24(6). PMC: 8503750. DOI: 10.3892/mmr.2021.12474. View

11.

Freedman B, Hwang C, Talbot S, Hibler B, Matoori S, Mooney D . Breakthrough treatments for accelerated wound healing. Sci Adv. 2023; 9(20):eade7007. PMC: 10191440. DOI: 10.1126/sciadv.ade7007. View

12.

Wang X, Jiang G, Zong J, Lv D, Lu M, Qu X . Revealing the novel ferroptosis-related therapeutic targets for diabetic foot ulcer based on the machine learning. Front Genet. 2022; 13:944425. PMC: 9549267. DOI: 10.3389/fgene.2022.944425. View

13.

Huang Y, Kyriakides T . The role of extracellular matrix in the pathophysiology of diabetic wounds. Matrix Biol Plus. 2021; 6-7:100037. PMC: 7852307. DOI: 10.1016/j.mbplus.2020.100037. View

14.

Wu Y, La Pierre D, Wu J, Yee A, Yang B . The interaction of versican with its binding partners. Cell Res. 2005; 15(7):483-94. DOI: 10.1038/sj.cr.7290318. View

15.

Carvalho A, Lu J, Francis J, Moore R, Haley K, Doster R . S100A12 in Digestive Diseases and Health: A Scoping Review. Gastroenterol Res Pract. 2020; 2020:2868373. PMC: 7061133. DOI: 10.1155/2020/2868373. View

16.

Krisp C, Jacobsen F, McKay M, Molloy M, Steinstraesser L, Wolters D . Proteome analysis reveals antiangiogenic environments in chronic wounds of diabetes mellitus type 2 patients. Proteomics. 2013; 13(17):2670-81. DOI: 10.1002/pmic.201200502. View

17.

Jeon B, Choi H, Kang J, Tak M, Park E . Comparison of five systems of classification of diabetic foot ulcers and predictive factors for amputation. Int Wound J. 2016; 14(3):537-545. PMC: 7949506. DOI: 10.1111/iwj.12642. View

18.

Goodarzi G, Maniati M, Qujeq D . The role of microRNAs in the healing of diabetic ulcers. Int Wound J. 2019; 16(3):621-633. PMC: 7949391. DOI: 10.1111/iwj.13070. View

19.

Ponten F, Jirstrom K, Uhlen M . The Human Protein Atlas--a tool for pathology. J Pathol. 2008; 216(4):387-93. DOI: 10.1002/path.2440. View

20.

Rodrigues B, Vangaveti V, Urkude R, Biros E, Malabu U . Prevalence and risk factors of lower limb amputations in patients with diabetic foot ulcers: A systematic review and meta-analysis. Diabetes Metab Syndr. 2022; 16(2):102397. DOI: 10.1016/j.dsx.2022.102397. View